Literature DB >> 24789582

Myocardial signal intensity decay after gadolinium injection: a fast and effective method for the diagnosis of cardiac amyloidosis.

Giovanni Donato Aquaro1, Nicola Riccardo Pugliese, Federico Perfetto, Francesco Cappelli, Andrea Barison, Pier Giorgio Masci, Claudio Passino, Michele Emdin.   

Abstract

Late Gadolinium Enhancement (LGE) pattern of cardiac amyloidosis (CA) at cardiac magnetic resonance (CMR) examination is absent in approximately 30% of patients. We tested whether the evaluation of myocardial gadolinium signal intensity (SI) decay (SID) has a higher diagnostic accuracy for CA. CMR was performed in 59 patients with systemic AL amyloidosis (36 males, 69 ± 10 years, mean ± SD), and 20 age/sex-matched healthy controls. LGE images were acquired every minute up to 8 min after gadolinium injection (time of inversion 250 ms). SI regions of interest were plotted in SI/time curves for endocardial (Endo) and epicardial layer of interventricular septum, cavity, and skeletal muscle as reference. SID (a negative exponential function described by the parameter TSID) was expressed as number of heart beats (HB) from each ROI. The typical LGE pattern for CA was detected in 42 patients (Ty-LGE), while 17 showed either absent LGE or an atypical pattern (ATy-LGE). A definite CA diagnosis was confirmed in all Ty-LGE patients and in 10/17 ATy-LGE patients. At ROC analysis Endo-TSID was the most accurate parameter to distinguish Ty-LGE and ATy-LGE patients from controls. A 269 HB threshold (mean + 2 SD Endo-TSID measured in controls) identified 51/52 patients with definite CA diagnosis, with 98% sensitivity, 93% specificity, and 96% diagnostic accuracy. A direct relation was found between the extracellular volume and Endo-TSID in CA patients (r 0.72, 95% CI 0.37-089, p < 0.001). the analysis of myocardial SID after gadolinium injection improves the accuracy of CMR for CA diagnosis.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24789582     DOI: 10.1007/s10554-014-0436-6

Source DB:  PubMed          Journal:  Int J Cardiovasc Imaging        ISSN: 1569-5794            Impact factor:   2.357


  20 in total

Review 1.  Diagnosis and management of the cardiac amyloidoses.

Authors:  Rodney H Falk
Journal:  Circulation       Date:  2005-09-27       Impact factor: 29.690

Review 2.  Quantification of cardiac function by conventional and cine magnetic resonance imaging.

Authors:  U Sechtem; P Pflugfelder; C B Higgins
Journal:  Cardiovasc Intervent Radiol       Date:  1987       Impact factor: 2.740

3.  Non-invasive evaluation of the myocardial substrate of cardiac amyloidosis by gadolinium cardiac magnetic resonance.

Authors:  E Perugini; C Rapezzi; T Piva; O Leone; L Bacchi-Reggiani; L Riva; F Salvi; L Lovato; A Branzi; R Fattori
Journal:  Heart       Date:  2005-06-06       Impact factor: 5.994

4.  Cardiovascular magnetic resonance in cardiac amyloidosis.

Authors:  Alicia Maria Maceira; Jayshree Joshi; Sanjay Kumar Prasad; James Charles Moon; Enrica Perugini; Idris Harding; Mary Noelle Sheppard; Philip Alexander Poole-Wilson; Philip Nigel Hawkins; Dudley John Pennell
Journal:  Circulation       Date:  2005-01-03       Impact factor: 29.690

5.  Myocardial blood flow and fibrosis in hypertrophic cardiomyopathy.

Authors:  Giovanni Donato Aquaro; Giancarlo Todiere; Andrea Barison; Elisabetta Strata; Mario Marzilli; Alessandro Pingitore; Massimo Lombardi
Journal:  J Card Fail       Date:  2011-02-26       Impact factor: 5.712

6.  Reference right ventricular systolic and diastolic function normalized to age, gender and body surface area from steady-state free precession cardiovascular magnetic resonance.

Authors:  Alicia M Maceira; Sanjay K Prasad; Mohammed Khan; Dudley J Pennell
Journal:  Eur Heart J       Date:  2006-11-06       Impact factor: 29.983

7.  Evaluation of diffuse myocardial fibrosis in heart failure with cardiac magnetic resonance contrast-enhanced T1 mapping.

Authors:  Leah Iles; Heinz Pfluger; Arintaya Phrommintikul; Joshi Cherayath; Pelin Aksit; Sandeep N Gupta; David M Kaye; Andrew J Taylor
Journal:  J Am Coll Cardiol       Date:  2008-11-04       Impact factor: 24.094

Review 8.  Estimating kinetic parameters from dynamic contrast-enhanced T(1)-weighted MRI of a diffusable tracer: standardized quantities and symbols.

Authors:  P S Tofts; G Brix; D L Buckley; J L Evelhoch; E Henderson; M V Knopp; H B Larsson; T Y Lee; N A Mayr; G J Parker; R E Port; J Taylor; R M Weisskoff
Journal:  J Magn Reson Imaging       Date:  1999-09       Impact factor: 4.813

9.  Shortened Modified Look-Locker Inversion recovery (ShMOLLI) for clinical myocardial T1-mapping at 1.5 and 3 T within a 9 heartbeat breathhold.

Authors:  Stefan K Piechnik; Vanessa M Ferreira; Erica Dall'Armellina; Lowri E Cochlin; Andreas Greiser; Stefan Neubauer; Matthew D Robson
Journal:  J Cardiovasc Magn Reson       Date:  2010-11-19       Impact factor: 5.364

10.  Cardiovascular magnetic resonance and prognosis in cardiac amyloidosis.

Authors:  Alicia M Maceira; Sanjay K Prasad; Philip N Hawkins; Michael Roughton; Dudley J Pennell
Journal:  J Cardiovasc Magn Reson       Date:  2008-11-25       Impact factor: 5.364

View more
  9 in total

Review 1.  Pathophysiology and treatment of cardiac amyloidosis.

Authors:  Morie A Gertz; Angela Dispenzieri; Taimur Sher
Journal:  Nat Rev Cardiol       Date:  2014-10-14       Impact factor: 32.419

Review 2.  Recent advances in the noninvasive strategies of cardiac amyloidosis.

Authors:  Lei Zhao; Quan Fang
Journal:  Heart Fail Rev       Date:  2016-11       Impact factor: 4.214

3.  Electromechanical dissociation of left atrium in patients with Cardiac Amyloidosis by Magnetic Resonance: Prognostic and clinical correlates.

Authors:  Giovanni Donato Aquaro; Sofia Morini; Chrysanthos Grigoratos; Giulia Taborchi; Gianluca Di Bella; Raffaele Martone; Elisa Vignini; Michele Emdin; Iacopo Olivotto; Federico Perfetto; Francesco Cappelli
Journal:  Int J Cardiol Heart Vasc       Date:  2020-09-14

Review 4.  Sudden cardiac death from structural heart diseases in adults: imaging findings with cardiovascular computed tomography and magnetic resonance.

Authors:  Song Soo Kim; Sung Min Ko; Sang Il Choi; Bo Hwa Choi; Arthur E Stillman
Journal:  Int J Cardiovasc Imaging       Date:  2016-05-02       Impact factor: 2.357

Review 5.  Cardiovascular magnetic resonance for amyloidosis.

Authors:  Marianna Fontana; Robin Chung; Philip N Hawkins; James C Moon
Journal:  Heart Fail Rev       Date:  2015-03       Impact factor: 4.214

6.  Deep learning to diagnose cardiac amyloidosis from cardiovascular magnetic resonance.

Authors:  Nicola Martini; Alberto Aimo; Andrea Barison; Daniele Della Latta; Giuseppe Vergaro; Giovanni Donato Aquaro; Andrea Ripoli; Michele Emdin; Dante Chiappino
Journal:  J Cardiovasc Magn Reson       Date:  2020-12-07       Impact factor: 5.364

7.  Amyloid Deposits and Fibrosis on Left Ventricular Endomyocardial Biopsy Correlate With Extracellular Volume in Cardiac Amyloidosis.

Authors:  Angela Pucci; Alberto Aimo; Veronica Musetti; Andrea Barison; Giuseppe Vergaro; Dario Genovesi; Assuero Giorgetti; Silvia Masotti; Chiara Arzilli; Concetta Prontera; Luigi Emilio Pastormerlo; Michele Alessandro Coceani; Marco Ciardetti; Nicola Martini; Cataldo Palmieri; Claudio Passino; Claudio Rapezzi; Michele Emdin
Journal:  J Am Heart Assoc       Date:  2021-10-08       Impact factor: 5.501

8.  Diagnostic performance of CMR, SPECT, and PET imaging for the detection of cardiac amyloidosis: a meta-analysis.

Authors:  Zhaoye Wu; Chunjing Yu
Journal:  BMC Cardiovasc Disord       Date:  2021-10-07       Impact factor: 2.298

Review 9.  Diagnostic accuracy of cardiovascular magnetic resonance for patients with suspected cardiac amyloidosis: a systematic review and meta-analysis.

Authors:  Lei Zhao; Zhuang Tian; Quan Fang
Journal:  BMC Cardiovasc Disord       Date:  2016-06-07       Impact factor: 2.298

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.